259 related articles for article (PubMed ID: 35367665)
1. Macrophage SCAP Contributes to Metaflammation and Lean NAFLD by Activating STING-NF-κB Signaling Pathway.
Huang X; Yao Y; Hou X; Wei L; Rao Y; Su Y; Zheng G; Ruan XZ; Li D; Chen Y
Cell Mol Gastroenterol Hepatol; 2022; 14(1):1-26. PubMed ID: 35367665
[TBL] [Abstract][Full Text] [Related]
2. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.
Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L
Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
4. Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages.
Ouyang N; Gan H; He Q; Lei H; Wang SY; Liu Q; Zhou C
Exp Cell Res; 2018 Jun; 367(2):162-169. PubMed ID: 29596892
[TBL] [Abstract][Full Text] [Related]
5. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
6. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
7. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
Li YN; Su Y
Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926
[TBL] [Abstract][Full Text] [Related]
8. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation.
Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ
Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792
[TBL] [Abstract][Full Text] [Related]
10.
Zhao W; Guo M; Feng J; Gu Z; Zhao J; Zhang H; Wang G; Chen W
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565666
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages.
Cao L; Xu E; Zheng R; Zhangchen Z; Zhong R; Huang F; Ye J; Sun H; Fan Y; Xie S; Chen Y; Xu Y; Cao J; Cao W; Liu C
Chin Med; 2022 Jan; 17(1):7. PubMed ID: 34983596
[TBL] [Abstract][Full Text] [Related]
12. PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway.
Li Z; Wu K; Zou Y; Gong W; Wang P; Wang H
Toxicol Appl Pharmacol; 2022 Aug; 448():116074. PubMed ID: 35605788
[TBL] [Abstract][Full Text] [Related]
13. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
14. SCAP deficiency facilitates obesity and insulin resistance through shifting adipose tissue macrophage polarization.
Lee JH; Lee SH; Lee EH; Cho JY; Song DK; Lee YJ; Kwon TK; Oh BC; Cho KW; Osborne TF; Jeon TI; Im SS
J Adv Res; 2023 Mar; 45():1-13. PubMed ID: 35659922
[TBL] [Abstract][Full Text] [Related]
15.
Li X; Tang X; Xiang Y; Zhao Z; Li Y; Ding Q; Zhang L; Xu J; Zhao L; Chen Y
Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G697-G711. PubMed ID: 38591127
[TBL] [Abstract][Full Text] [Related]
16. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF-κB signaling pathway.
Yao C; Lan D; Li X; Wang Y; Qi S
Oral Dis; 2024 Apr; 30(3):1680-1694. PubMed ID: 36939447
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
19. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
20. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
